Fall has descended upon us, along with that nip in the air and the aroma of pumpkin spice. All of these herald our latest edition of Pro Te: Solutio, which contains three fascinating articles on topics of current interest in...more
3/14/2019
/ 21st Century Cures Act ,
510(k) RTA ,
Causation ,
Daubert Standards ,
Design Defects ,
Expert Testimony ,
Expert Witness ,
FDA Reauthorization Act ,
Food and Drug Administration (FDA) ,
Litigation Strategies ,
Medical Devices ,
Strict Product Liability
In this issue of Pro Te (Volume 11, No.2), we examine three important topics with practical implications.
In many jurisdictions, the medical judgment of physicians is almost sacrosanct – at least insofar as it is...more
9/21/2018
/ 21st Century Cures Act ,
Dismissal With Prejudice ,
FDA Approval ,
Food and Drug Administration (FDA) ,
Medical Devices ,
New Guidance ,
Patients ,
Pharmaceutical Industry ,
Physicians ,
Prescription Drugs ,
Regulatory Oversight ,
Statute of Limitations
It’s hard to believe a decade has passed since we delivered our first edition of Pro Te: Solutio to your door. Those years have brought enormous changes in the world and in our industry. Innovation has driven everything we...more
7/17/2018
/ 21st Century Cures Act ,
Affordable Care Act ,
Client Services ,
Depositions ,
DQSA ,
Emergency Response ,
Enforcement Actions ,
FDASIA ,
Food and Drug Administration (FDA) ,
Food and Drug Administration Amendments Act (FDAAA) ,
Health Care Providers ,
Health Insurance ,
Hospitals ,
Innovation ,
Juror ,
Jury Trial ,
Law Firm Associates ,
Law Firm Ownership ,
Law Firm Partners ,
Law Practice Management ,
Manufacturers ,
Medical Device User Fee Program (MDUFA IV) ,
Medical Devices ,
Multidistrict Litigation ,
Patient Rights ,
Patient Safety ,
Patients ,
Pharmaceutical Industry ,
Preemption ,
Questionnaires ,
Reporting Requirements ,
State Law Tort Claims ,
Voir Dire ,
Witness Preparation
It’s Spring! In this issue of Pro Te, we do a little a “spring cleaning” to brush the dust off some familiar topics that we consider in day-to-day pharmaceutical litigation. In The Forgotten Element? Warnings Proximate...more